Open Science Research Excellence

ICADLLM 2020 : International Conference on Advanced Drugs for Leukemia, Lymphoma and Myeloma

London, United Kingdom
May 21 - 22, 2020

International Scientific Committee

Faris Abachi   University of Mosul, IQ
Konstantinos Fragkos   University College London, UK
W John Martin   Institute of Progressive Medicine, US
Md Nafiujjaman   Michigan State University, US
Leroy Davis   Gene Evolution Project, Llc, US
Dave Milzman   University of Maryland School of Medicine, US
Sorush Niknamian   Liberty University, US
Asad Moten   Department of Defense, US
Peter Panagos   Washington University, US
Muthu Dhandapani   Mitra Biotech, US
Fayez Safadi   Northeast Ohio Medical University (neomed), US
Manju Bhaskar   National Institutes of Health, US
Gaowei Mao   University of Pittsburgh, US
Ketevan Tavamaishvili   Intellewave Inc, US
Ehsan Kamrani   Harvard University, US
Shailender Singh Kanwar   University of Michigan, US
Sajeesh Kumar   University of Tenessee Hsc, US
Gurmukh Singh   Fredonia State University, US
Rolf Konig   University of Texas Medical Branch, US
Shashikant Srivastava   Ut Southwestern Medical Center, US
Jun San Juan   Loras College, US
Subeena Sood   Medstar Health Research Institute, US
Xueji Zhang   University of South Floirda, US
Hector Velasco   Morgan State University School of Community Health and Policy, US
Zhengwu Lu   Abbott Laboratories, US
David Stiles   Medtronic, US
Ching-An Peng   Michigan Technological University, US
Shankar Krishnan   Wentworth Institute of Technology, US
Raymond Vazquez   Dstceur, US
Luisetto Mauro   Ima Academy, IT
Loganahan Salvaraji   University Malaysia Sabah, MY
Alper Başa   Fırat University, TR
Hema Gupta   Health Canada, CA
Gracelyn Portia Francis   University of Eastern Africa, Baraton, KE
Hamzeh Rahimi   Pasteur Institute of Iran, IR